Is Family Care overvalued or undervalued?
As of October 17, 2025, Family Care is fairly valued with a PE ratio of 0.79 and strong financial metrics, making it more attractive compared to peers like Max Healthcare and Apollo Hospitals, despite its recent stock performance lagging behind the Sensex.
As of 17 October 2025, the valuation grade for Family Care has moved from expensive to fair. This indicates a shift in perception regarding the company's market value. Based on the analysis, Family Care appears to be fairly valued at this time. The company has a PE ratio of 0.79, an EV to EBITDA ratio of 0.95, and an impressive ROE of 219.63%, which are strong indicators of its financial health.When compared to peers, Family Care's valuation metrics stand out. For instance, Max Healthcare is considered very expensive with a PE ratio of 97.05, while Apollo Hospitals is fairly valued with a PE of 72.25. This comparison underscores Family Care's relative attractiveness in the healthcare services sector. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -35.14% compared to the Sensex's 7.44%, highlighting the potential for recovery as the valuation aligns more closely with its fundamentals.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
